Ngā hua rapu - David A. Scheinberg

Whakamahine hua
  1. 1
    Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

    Actinium-225 in Targeted Alpha-Particle Therapeutic Applications mā David A. Scheinberg, Michael R. McDevitt

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications

    Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications mā Matthias Miederer, David A. Scheinberg, Michael R. McDevitt

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with <sup>225</sup>Ac for α-Particle Radioimmunotherapy of Cancer

    Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with <sup>225</sup>Ac for α-Particle Radioimmunotherapy of Cancer mā William F. Maguire, Michael R. McDevitt, Peter Smith‐Jones, David A. Scheinberg

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Chimeric and humanized antibodies with specificity for the CD33 antigen.

    Chimeric and humanized antibodies with specificity for the CD33 antigen. mā M S Co, N M Avdalovic, Philip Caron, Mark Avdalovic, David A. Scheinberg, Cary Queen

    I whakaputaina 1992
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase

    Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase mā De-Ming Chau, Christina J. Crump, Jennifer C. Villa, David A. Scheinberg, Yue‐Ming Li

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Carbon nanotubes as vaccine scaffolds

    Carbon nanotubes as vaccine scaffolds mā David A. Scheinberg, Michael R. McDevitt, Tao Dao, J. Justin Mulvey, Evan N. Feinberg, Simone Alidori

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers

    Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers mā Stavroula Sofou, Barry J. Kappel, Jaspreet Singh Jaggi, Michael R. McDevitt, David A. Scheinberg, George Sgouros

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia

    Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia mā Joseph G. Jurcic, Stephen D. Nimer, David A. Scheinberg, Tony DeBlasio, Raymond P. Warrell, Wilson H. Miller

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters

    Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters mā Jaspreet Singh Jaggi, Surya V. Seshan, Michael R. McDevitt, Krista LaPerle, George Sgouros, David A. Scheinberg

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia mā Kathleen N. S. Cathcart, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Joseph E. Schwartz, Victoriya Zakhaleva, Esperanza B. Papadopoulos, David A. Scheinberg

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics

    Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics mā Niloufar Ataie, Jingyi Xiang, Neal Cheng, Elliott J. Brea, Wenjie Lu, David A. Scheinberg, Liu C, Ho Leung Ng

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

    Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs mā Mark Heaney, Jeffrey R. Gardner, Nicos Karasavvas, David W. Golde, David A. Scheinberg, Emily A. Smith, Owen A. O’Connor

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells

    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells mā Rena J. May, Tao Dao, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, P. Maslak, David A. Scheinberg

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

    Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen mā Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan, Mythili Koneru, Tao Dao, C Liu, David A. Scheinberg, Renier J. Brentjens

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Rejection of immunogenic tumor clones is limited by clonal fraction

    Rejection of immunogenic tumor clones is limited by clonal fraction mā Ron S. Gejman, Aaron Y. Chang, Heather F. Jones, Krysta M. DiKun, A. Ari Hakimi, Andrea Schietinger, David A. Scheinberg

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias

    A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias mā Leonid Dubrovsky, Dmitry Pankov, Elliott J. Brea, Tao Dao, Andrew Scott, Su Yan, Richard J. O’Reilly, Liu C, David A. Scheinberg

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Opportunities and challenges for TCR mimic antibodies in cancer therapy

    Opportunities and challenges for TCR mimic antibodies in cancer therapy mā Aaron Y. Chang, Ron S. Gejman, Elliott J. Brea, Claire Y. Oh, Melissa Mathias, Dmitry Pankov, Emily Casey, Tao Dao, David A. Scheinberg

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors

    Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors mā Freddy E. Escorcia, Erik Henke, Michael R. McDevitt, Carlos H. Villa, Peter Smith‐Jones, Ronald G. Blasberg, Robert Benezra, David A. Scheinberg

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody

    Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody mā Jazmin Schwartz, Jaspreet Singh Jaggi, Joseph A. O’Donoghue, Shanming Ruan, Michael R. McDevitt, Steven M. Larson, David A. Scheinberg, John L. Humm

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

    A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia mā Prabodhika Mallikaratchy, Alessandro Ruggiero, Jeffrey R. Gardner, Vitaly Kuryavyi, William F. Maguire, Mark Heaney, Michael R. McDevitt, Dinshaw J. Patel, David A. Scheinberg

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: